On Wednesday morning, Johnson & Johnson (NYSE:JNJ) published its second-quarter earnings report, but this wasn't greeted ...

Johnson & Johnson, in a motion for order to show cause, insisted that lead plaintiffs’ counsel in the talc multidistrict ...

Johnson & Johnson JNJ shares rose in early trading on Thursday, after the company reported upbeat second-quarter results. • ...

The drug and medical-device maker raised its forecast for the year after recording higher sales in the second quarter.

The drugmaker posts earnings that narrowly beat expectations and raises its full-year outlook.

Johnson & Johnson JNJ on Wednesday reported second-quarter 2026 results that topped Wall Street estimates and raised its full ...

The healthcare giant's second-quarter earnings will shine the spotlight on its exciting new products and pipeline.

Johnson & Johnson (NYSE: JNJ) today announced with TIME the launch of the Healthcare Champion of the Year. The new branded recognition will honor healthcare professionals in the U.S., selected by ...

Johnson & Johnson (NYSE:JNJ) announced today that it received FDA approval for its dual-energy ThermoCool SmartTouch SF ...

Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript ...

Johnson & Johnson's Tom Aelbrecht, N-VA's Jan Jambon, Flemish Minister for Welfare and Culture Caroline Gennez, Deputy department head of the nursing department Siska Van den Bergh, ZAS president Els ...

On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked her parents to stay home from school, and they gave her one ...